KALV · Categories · Form 3

KALV - SEC Form 3 initial insider statements

KalVista Pharmaceuticals Inc. (KALV) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for KALV

• 237d
  SEC Form 3 filed by new insider Arif Bilal

  3 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)
• 244d
  SEC Form 3 filed by new insider Sensenig Bethany

  3 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)
• 281d
  SEC Form 3 filed by new insider Sweeny Nicole

  3 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)
• 484d
  New insider Venrock Healthcare Capital Partners Iii, L.P. claimed ownership of 4,942,773 shares (SEC Form 3)

  3 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)
• 554d
  SEC Form 3 filed by new insider Reid Laurence

  3 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)
• 630d
  SEC Form 3 filed by new insider Piekos Brian

  3 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)
• 772d
  SEC Form 3 filed by new insider Fairey William

  3 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)
• 888d
  New insider Venrock Healthcare Capital Partners Iii, L.P. claimed ownership of 3,573,714 shares (SEC Form 3)

  3 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)
• 1856d
  SEC Form 3 filed by Audhya Paul K.

  3 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)
• 1901d
  SEC Form 3 filed by Nancy Stuart

  3 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)

Other KALV categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends